Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Atrix Laboratories

This article was originally published in The Gray Sheet

Executive Summary

Atrix Laboratories: Receives 510(k) clearance from FDA for the Atrisorb barrier for guided tissue regeneration (GTR), its first product. Atrisorb, based on Atrix' Atrigel biodegradable polymer technology, is already being rolled out in Denmark, France, Spain, Switzerland, "and several other European countries," Atrix says. Shipments of the product to the U.S. periodontal community, which represents its largest potential market, are expected to begin in June, the firm says. The Fort Collins, Colorado-based company notes that clearance of the 510(k) comes 90 days after its filing...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005710

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel